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In recent years, discovery of the in vitro and in vivo differentiation of APL blasts by all-trans retinoic acid (ATRA) has modified the therapeutic approach of APL and has also led to important advances in understanding the biology of APL, opening new perspectives for differentialion therapy in cancer (6.-b).
MOLECULAR BASIS OF APL
Through the t(15;17) translocation (2) , AML3 leukemic cells harbor PML/RARa fusion transcripts ( Fig. 1 ) and, to a lesser extent (70% of patients only), the reciprocal RARaJPML transcripts. On the other hand, the recently identified PML and PLZF proteins are both nuclear proteins that possess domains significant for efficient transactivation processes.
In normal cells, PML protein is specifi- L., Degos. L., Paul, P., and Chomienne, C. (1996) 
